Top

Reactions Weekly

Published in:

01-10-2023 | Rheumatoid Arthritis | Case report

GSK-137173A

Flare of rheumatoid arthritis: case report

Published in: Reactions Weekly | Issue 1/2023

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Andreica I, et al. TOLERABILITY AND SAFETY OF RECOMBINANT ZOSTER VACCINE IN PATIENTS WITH INFLAMMATORY RHEUMATIC MUSCULOSKELETAL DISEASES-A PROSPECTIVE LONGITUDINAL STUDY OVER 6 MONTHS. Annals of the Rheumatic Diseases 82 (Suppl. 1) : 550-551, Jun 2023. Available from: URL: http://doi.org/10.1136/annrheumdis-2023-eular.2827 [abstract]

Title: GSK-137173A
Flare of rheumatoid arthritis: case report
Publication date: 01-10-2023
Publisher: Springer International Publishing
Keywords: Rheumatoid Arthritis
Shingles
Published in: Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-47937-6

Keynote webinar | Spotlight on medication adherence

Springer Medicine

GSK-137173A

Flare of rheumatoid arthritis: case report

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2023

Hydroxychloroquine

No new or worrying AEs after influenza or pneumococcal vaccination

Antithrombotics

Olanzapine

Ketamine/opioid-analgesics

Hydralazine